HF007 - Heart Failure review
Indicator definition
Indicator ID | |
| The percentage of patients with a diagnosis of heart failure on the register, who have had a review in the preceding 12 months, including an assessment of functional capacity and a review of medication to ensure medicines optimisation at maximal tolerated doses.
|
What do the business rules mean?
What makes a patient eligible?
Patients are eligible for the HF007 denominator if they are on the Heart Failure register (regardless of left ventricular systolic dysfunction or reduced ejection fraction). What will remove patients from eligibility?
- Patients for whom heart failure quality indicator care was unsuitable in the contract year
- Patients who chose not to receive a medication review in the contract year
- Patients who have been invited twice (at least 7 days apart) within the contract year
- Patients who were diagnosed with heart failure in the last 3 months of the contract year
- Patients who were newly registered with the practice in the last 3 months of the contract year

If a patient achieves the
indicator at any point during the year, any exclusions that have also been
added are ignored.
SNOMED codes used in this indicator

The codes referenced in this article are taken from the NHS Technology Reference Update Distribution (TRUD). Not all of these may be present or selectable in all clinical systems.
Codes for heart failure quality indicator care unsuitable for patient (HFPCAPU_COD)
SNOMED code | SNOMED code description |
717481000000104 | Excepted from heart failure quality indicators - patient unsuitable
|
Codes indicating the patient has chosen not to receive a medication review (MEDRVWDEC_COD)
SNOMED code | SNOMED code description |
286291000000107 | Dispensing review of use of medicines declined |
412725004 | Medication review declined
|
Codes indicating the patient has chosen not to receive heart failure quality indicator care (HFPCADEC_COD)
SNOMED code | SNOMED code description |
717491000000102 | Excepted from heart failure quality indicators - informed dissent
|
Invite for heart failure care review codes (HFINVITE_COD)
SNOMED code | SNOMED code description |
1109921000000106 | Quality and Outcomes Framework quality indicator-related care invitation |
1110931000000103 | Quality and Outcomes Framework heart failure quality indicator-related care invitation |
143411000000100 | Quality and Outcomes Framework heart failure quality indicator-related care invitation using preferred method of communication |
711461000000104 | Heart failure monitoring invitation |
716621000000101 | Heart failure monitoring third letter |
716971000000109 | Heart failure monitoring first letter |
717191000000108 | Heart failure monitoring second letter |
717501000000108 | Heart failure monitoring verbal invitation |
717531000000102 | Heart failure monitoring telephone invitation |
Heart failure review codes (HFRVW_COD)
SNOMED code | SNOMED code description |
134378009 | Congestive heart failure monitoring |
202231000000106 | Heart failure review completed |
247361000000100 | Heart failure 6 month review |
390885007 | Heart failure annual review |
810971000000105 | Heart failure self-management plan review |
813991000000101 | Education about deteriorating heart failure |
851071000000108 | Heart failure initial assessment |
871681000000102 | Heart failure monitoring |
872361000000105 | Discussion about heart failure care plan |
Heart failure medication review codes (HFMEDRVW_COD)
SNOMED code | SNOMED code description |
473226007 | Heart failure medication review |
Medication review codes (MEDRVW_COD)
SNOMED code | SNOMED code description |
1079381000000109 | Medication review by community nurse |
1127441000000107 | Medication review done by clinical pharmacist |
1239511000000100 | Structured medication review |
182836005 | Review of medication |
314530002 | Medication review done |
391156007 | Medication review without patient |
719326006 | Medication review done by pharmacy technician |
719327002 | Medication review done by community pharmacist |
719328007 | Medication review done by doctor |
719329004 | Medication review done by pharmacist |
719478008 | Medication review done by nurse |
803361000000109 | Medication review by practice nurse |
870661000000100 | Polypharmacy medication review |
88551000000109 | Medication review with patient |
961831000000100 | Medication review done by medicines management pharmacist |
961861000000105 | Medication review done by medicines management technician |
Related Articles
HF006 - Heart Failure on a beta-blocker
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description HF006 The percentage of patients with a diagnosis of heart failure due to ...
HF003 - Heart Failure on ACEi or ARB
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description HF003 In those patients with a diagnosis of heart failure due to left ...
HF001 - Heart Failure register
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). This indicator is protected in the contract year 2024/25 and will be paid at 2023/24 performance levels Indicator ...
HF008 - New Heart Failure diagnosis with echo or specialist assessment
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). Indicator definition Indicator ID Description HF008 The percentage of patients with a diagnosis of heart failure on or ...
CHD001 - Coronary Heart Disease register
The information contained within this article is from version 49 of the Business Rules for Quality and Outcomes Framework (QOF). This indicator is protected in the contract year 2024/25 and will be paid at 2023/24 performance levels Indicator ...